PharmacyCodes



Streptonivicin en es it fr

Streptonivicin Brand names, Streptonivicin Analogs

Streptonivicin Brand Names Mixture

  • Albacillin Suspension (Novobiocin (Novobiocin Sodium) + Penicillin G Procaine)
  • Delta-Albaplex Tablets (Novobiocin (Novobiocin Sodium) + Prednisolone + Tetracycline Hydrochloride)
  • Novodry Plus Suspension (Novobiocin (Novobiocin Sodium) + Penicillin G Procaine)
  • Special Formula 17900-Forte Suspension (Dihydrostreptomycin (Dihydrostreptomycin Sulfate) + Hydrocortisone Acetate + Hydrocortisone Sodium Succinate + Novobiocin (Novobiocin Sodium) + Penicillin G Procaine + Polymyxin B Sulfate)

Streptonivicin Chemical_Formula

C31H36N2O11

Streptonivicin RX_link

No information avaliable

Streptonivicin fda sheet

Streptonivicin msds (material safety sheet)

Streptonivicin MSDS

Streptonivicin Synthesis Reference

No information avaliable

Streptonivicin Molecular Weight

612.624 g/mol

Streptonivicin Melting Point

No information avaliable

Streptonivicin H2O Solubility

Insoluble

Streptonivicin State

Solid

Streptonivicin LogP

2.737

Streptonivicin Dosage Forms

Drug premix; Suspension

Streptonivicin Indication

For the treatment of infections due to staphylococci and other susceptible organisms

Streptonivicin Pharmacology

Novobiocin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.

Streptonivicin Absorption

No information avaliable

Streptonivicin side effects and Toxicity

No information avaliable

Streptonivicin Patient Information

No information avaliable

Streptonivicin Organisms Affected

Enteric bacteria and other eubacteria